Sugi Predict

Sugi Predict / Compounds / SCHEMBL4151256

SCHEMBL4151256

SCHEMBL4151256

CCOC(=O)c1ccc2c(c(C=Cc3cccc(C(C)=O)c3)nn2C(c2ccccc2)(c2ccccc2)c2ccccc2)c1OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 6/20 0.36
▸ FNTA P49354 1/20 0.35
▸ FNTB P49356 1/20 0.35
▸ POLB P06746 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ TP53 P04637 5/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ LMNA P02545 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ NR1I2 O75469 1/20 0.33
▸ CHRM2 P08172 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ OPRM1 P35372 1/20 0.33
▸ OPRD1 P41143 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4151252 1.00 ELANE (0.36) ELANEFNTAFNTBPOLBALDH1A1
SCHEMBL4149027 0.91 FNTA (0.35) ELANEFNTAFNTBPOLBALDH1A1
SCHEMBL4149033 0.91 FNTA (0.35) ELANEFNTAFNTBPOLBALDH1A1
SCHEMBL4143996 0.89 ELANE (0.36) ELANEFNTAFNTBPOLBALDH1A1
SCHEMBL4144001 0.89 ELANE (0.36) ELANEFNTAFNTBPOLBALDH1A1
SCHEMBL4157675 0.86 MAPK1 (0.38) ELANEFNTAFNTBPOLBALDH1A1
SCHEMBL4157669 0.86 MAPK1 (0.38) ELANEFNTAFNTBPOLBALDH1A1
SCHEMBL13927716 0.86 TP53 (0.37) ELANEFNTAFNTBALDH1A1TP53
SCHEMBL4144588 0.84 TUBB4A (0.36) ELANEFNTAFNTBALDH1A1NPC1
SCHEMBL4144586 0.84 TUBB4A (0.36) ELANEFNTAFNTBALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054397-A1 PYRAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND OHI NORIHITO 2009-02-26 — — US disclosed
US-7429609-B2 Pyrazole compound and medicinal composition containing the same EISAI R & D MANAGEMENT CO., LTD. (JP) 2008-09-30 — — US disclosed
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-24 — — US disclosed
US-20050208582-A1 Pyrazole compounds and pharmaceutical compositions comprising the compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-09-22 — — US disclosed
EP-1510516-A1 PYRAZOLE COMPOUND AND MEDICINAL COMPOSITION CONTAINING THE SAME Eisai Co., Ltd. (JP) 2005-03-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054397-A1 PYRAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND CNKSR1, NR3C2, CSNK2B ELANE 3610/4885FNTA 4332/4885FNTB 3365/4885
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same CNKSR1, NR3C2, CSNK2B ELANE 3685/4885FNTA 4348/4885FNTB 3312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.